{"transactions":[{"id":730657,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36383,"kind":"person","name":"Jarrett Jennifer","position":1,"cik":"0001671311","reported_name":"Jarrett Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:21.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001671311-26-000005","document":"form4-06222026_040612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000167131126000005/form4-06222026_040612.xml","form_type":"4"}},{"id":730656,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36382,"kind":"person","name":"Thiara Parvinder","position":1,"cik":"0001995535","reported_name":"Thiara Parvinder","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:16.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001995535-26-000008","document":"form4-06222026_040610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000199553526000008/form4-06222026_040610.xml","form_type":"4"}},{"id":730655,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:14.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001867508-26-000002","document":"form4-06222026_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000186750826000002/form4-06222026_040609.xml","form_type":"4"}},{"id":730654,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36380,"kind":"person","name":"Nirula Ajay","position":1,"cik":"0002116832","reported_name":"Nirula Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:13.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0002116832-26-000007","document":"form4-06222026_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000211683226000007/form4-06222026_040607.xml","form_type":"4"}},{"id":730653,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":34471,"kind":"person","name":"Munshi Amit","position":1,"cik":"0001612551","reported_name":"Munshi Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:09.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001612551-26-000002","document":"form4-06222026_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000161255126000002/form4-06222026_040605.xml","form_type":"4"}},{"id":730652,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:07.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001834161-26-000008","document":"form4-06222026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000183416126000008/form4-06222026_040603.xml","form_type":"4"}},{"id":730650,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36378,"kind":"person","name":"Becker Daniel J.","position":1,"cik":"0001752139","reported_name":"Becker Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:05.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001752139-26-000002","document":"form4-06222026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000175213926000002/form4-06222026_040601.xml","form_type":"4"}},{"id":819824,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54274,"kind":"person","name":"Whale Gary","position":1,"cik":"0001965860","reported_name":"Whale Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-04-02T22:00:24.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":263000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":263000,"derivative":{"exercise_price":6.03,"expiration_date":"2036-04-01","underlying":"Class A Ordinary Shares","underlying_shares":263000},"source":{"system":"sec-edgar","filing":"0001965860-26-000002","document":"form4-04022026_060420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000196586026000002/form4-04022026_060420.xml","form_type":"4"}},{"id":819823,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-04-02T22:00:21.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":340900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":340900,"derivative":{"exercise_price":6.03,"expiration_date":"2036-04-01","underlying":"Class A Ordinary Shares","underlying_shares":340900},"source":{"system":"sec-edgar","filing":"0001966926-26-000002","document":"form4-04022026_060416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000196692626000002/form4-04022026_060416.xml","form_type":"4"}},{"id":819822,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-04-02T22:00:20.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":425700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":425700,"derivative":{"exercise_price":6.03,"expiration_date":"2036-04-01","underlying":"Class A Ordinary Shares","underlying_shares":425700},"source":{"system":"sec-edgar","filing":"0001965590-26-000002","document":"form4-04022026_060414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000196559026000002/form4-04022026_060414.xml","form_type":"4"}},{"id":820094,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":24198,"kind":"person","name":"Kulkarni Sandeep Chidambar","position":1,"cik":"0001945691","reported_name":"Kulkarni Sandeep Chidambar","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-04-02T22:00:17.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":894000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":894000,"derivative":{"exercise_price":6.03,"expiration_date":"2036-04-01","underlying":"Class A Ordinary Shares","underlying_shares":894000},"source":{"system":"sec-edgar","filing":"0001945691-26-000005","document":"form4-04022026_060413.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945691/000194569126000005/form4-04022026_060413.xml","form_type":"4"}},{"id":820158,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54314,"kind":"person","name":"Nistala Kiran","position":1,"cik":"0002003539","reported_name":"Nistala Kiran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-04-02T18:00:23.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":340900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":340900,"derivative":{"exercise_price":6.03,"expiration_date":"2036-04-01","underlying":"Class A Ordinary Shares","underlying_shares":340900},"source":{"system":"sec-edgar","filing":"0002003539-26-000002","document":"form4-04022026_060418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003539/000200353926000002/form4-04022026_060418.xml","form_type":"4"}},{"id":858784,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36380,"kind":"person","name":"Nirula Ajay","position":1,"cik":"0002116832","reported_name":"Nirula Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-03-05T23:30:17.000Z","date":"2026-02-21","kind":"grant","planned":false,"acquired":true,"shares":37812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from February 21, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":37812,"derivative":{"exercise_price":6.53,"expiration_date":"2036-02-21","underlying":"Class A Ordinary Shares","underlying_shares":37812},"source":{"system":"sec-edgar","filing":"0002116832-26-000004","document":"form4-03052026_110314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000211683226000004/form4-03052026_110314.xml","form_type":"4"}},{"id":874644,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":47387,"kind":"organization","name":"AI Biotechnology LLC","position":1,"cik":"0001942670","reported_name":"AI Biotechnology LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46924,"kind":"organization","name":"Access Industries Holdings LLC","position":2,"cik":"0001391297","reported_name":"Access Industries Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46925,"kind":"organization","name":"ACCESS INDUSTRIES MANAGEMENT, LLC","position":3,"cik":"0001508226","reported_name":"ACCESS INDUSTRIES MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46929,"kind":"person","name":"Blavatnik Len","position":4,"cik":"0001326628","reported_name":"Blavatnik Len","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2026-03-02T22:55:03.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":6.25,"value":12500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by AI Biotechnology LLC (\"AIB\") and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."}],"balance_after":6552725,"source":{"system":"sec-edgar","filing":"0001193125-26-085900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1942670/000119312526085900/ownership.xml","form_type":"4"}},{"id":885210,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-02-25T02:14:02.000Z","date":"2026-02-21","kind":"grant","planned":false,"acquired":true,"shares":37812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from February 21, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":37812,"derivative":{"exercise_price":6.53,"expiration_date":"2036-02-21","underlying":"Class A Ordinary Shares","underlying_shares":37812},"source":{"system":"sec-edgar","filing":"0001834161-26-000006","document":"form4-02252026_020259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000183416126000006/form4-02252026_020259.xml","form_type":"4"}},{"id":930112,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36382,"kind":"person","name":"Thiara Parvinder","position":1,"cik":"0001995535","reported_name":"Thiara Parvinder","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-01-27T23:45:33.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":38823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from January 23, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of\nshareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":38823,"derivative":{"exercise_price":6.36,"expiration_date":"2036-01-23","underlying":"Class A Ordinary Shares","underlying_shares":38823},"source":{"system":"sec-edgar","filing":"0001995535-26-000006","document":"form4-01272026_110130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000199553526000006/form4-01272026_110130.xml","form_type":"4"}},{"id":932500,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":24198,"kind":"person","name":"Kulkarni Sandeep Chidambar","position":1,"cik":"0001945691","reported_name":"Kulkarni Sandeep Chidambar","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-01-23T22:56:36.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":2934107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on January 21, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":2934107,"derivative":{"exercise_price":6.32,"expiration_date":"2036-01-21","underlying":"Class A Ordinary Shares","underlying_shares":2934107},"source":{"system":"sec-edgar","filing":"0001945691-26-000003","document":"form4-01232026_100132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945691/000194569126000003/form4-01232026_100132.xml","form_type":"4"}},{"id":1085620,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-07-17T21:20:07.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":672000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on July 7, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":672000,"derivative":{"exercise_price":1.3,"expiration_date":"2035-07-15","underlying":"Class A Ordinary Shares","underlying_shares":672000},"source":{"system":"sec-edgar","filing":"0001415889-25-019965","document":"form4-07172025_090704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925019965/form4-07172025_090704.xml","form_type":"4"}},{"id":1130670,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36378,"kind":"person","name":"Becker Daniel J.","position":1,"cik":"0001752139","reported_name":"Becker Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-30T01:39:50.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.02,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014939","document":"form4-05302025_010547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014939/form4-05302025_010547.xml","form_type":"4"}},{"id":1137422,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:39:27.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014227","document":"form4-05222025_090523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014227/form4-05222025_090523.xml","form_type":"4"}},{"id":1137421,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:38:31.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014225","document":"form4-05222025_090527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014225/form4-05222025_090527.xml","form_type":"4"}},{"id":1137420,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":34471,"kind":"person","name":"Munshi Amit","position":1,"cik":"0001612551","reported_name":"Munshi Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:37:10.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014223","document":"form4-05222025_090505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014223/form4-05222025_090505.xml","form_type":"4"}},{"id":1137522,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":24198,"kind":"person","name":"Kulkarni Sandeep Chidambar","position":1,"cik":"0001945691","reported_name":"Kulkarni Sandeep Chidambar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:36:25.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014221","document":"form4-05222025_090521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945691/000141588925014221/form4-05222025_090521.xml","form_type":"4"}},{"id":1137419,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:35:36.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014219","document":"form4-05222025_090531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014219/form4-05222025_090531.xml","form_type":"4"}},{"id":1137418,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79404,"kind":"person","name":"Graham Neil Murray Hamilton","position":1,"cik":"0001952700","reported_name":"Graham Neil Murray Hamilton","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:34:15.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014217","document":"form4-05222025_090509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014217/form4-05222025_090509.xml","form_type":"4"}},{"id":1137417,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36383,"kind":"person","name":"Jarrett Jennifer","position":1,"cik":"0001671311","reported_name":"Jarrett Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:33:16.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014215","document":"form4-05222025_090513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014215/form4-05222025_090513.xml","form_type":"4"}},{"id":1152317,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-05-12T20:15:32.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":303100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":303100,"derivative":{"exercise_price":1.26,"expiration_date":"2035-05-08","underlying":"Class A Ordinary Shares","underlying_shares":303100},"source":{"system":"sec-edgar","filing":"0001415889-25-012656","document":"form4-05122025_040525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925012656/form4-05122025_040525.xml","form_type":"4"}},{"id":1236088,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54274,"kind":"person","name":"Whale Gary","position":1,"cik":"0001965860","reported_name":"Whale Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-03-03T22:03:45.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":302000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":302000,"derivative":{"exercise_price":1.2,"expiration_date":"2035-02-27","underlying":"Class A Ordinary Shares","underlying_shares":302000},"source":{"system":"sec-edgar","filing":"0001415889-25-006205","document":"form4-03032025_100340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925006205/form4-03032025_100340.xml","form_type":"4"}},{"id":1236087,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":82567,"kind":"person","name":"Lisicki Robert","position":1,"cik":"0001779614","reported_name":"Lisicki Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-03-03T22:01:42.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":1153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":1153000,"derivative":{"exercise_price":1.2,"expiration_date":"2035-02-27","underlying":"Class A Ordinary Shares","underlying_shares":1153000},"source":{"system":"sec-edgar","filing":"0001415889-25-006201","document":"form4-03032025_100338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925006201/form4-03032025_100338.xml","form_type":"4"}},{"id":1236085,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-03-03T22:00:44.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":488800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":488800,"derivative":{"exercise_price":1.2,"expiration_date":"2035-02-27","underlying":"Class A Ordinary Shares","underlying_shares":488800},"source":{"system":"sec-edgar","filing":"0001415889-25-006199","document":"form4-03032025_100340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925006199/form4-03032025_100340.xml","form_type":"4"}},{"id":1236268,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54314,"kind":"person","name":"Nistala Kiran","position":1,"cik":"0002003539","reported_name":"Nistala Kiran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-03-03T17:02:54.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":341700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":341700,"derivative":{"exercise_price":1.2,"expiration_date":"2035-02-27","underlying":"Class A Ordinary Shares","underlying_shares":341700},"source":{"system":"sec-edgar","filing":"0001415889-25-006203","document":"form4-03032025_100351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003539/000141588925006203/form4-03032025_100351.xml","form_type":"4"}},{"id":1267569,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-02-14T21:27:51.000Z","date":"2024-08-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2406573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":2406573},"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267568,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-02-14T21:27:51.000Z","date":"2024-08-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2783701,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":2783701},"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267567,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-02-14T21:27:51.000Z","date":"2023-10-30","kind":"purchase","planned":false,"acquired":true,"shares":2480000,"price":0.25,"value":620000.0,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The warrants were purchased by way of a private transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":2480000},"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267566,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-02-14T21:27:51.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":true,"shares":656573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The warrants were distributed by JATT to the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The warrants were distributed by JATT to the Reporting Person for no additional consideration."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":656573},"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267565,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-02-14T21:27:51.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":false,"shares":1464617,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"JATT distributed private placement warrants to its members with no consideration being paid in connection therewith."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"JATT distributed private placement warrants to its members with no consideration being paid in connection therewith."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":1464617},"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267564,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-02-14T21:27:51.000Z","date":"2023-06-23","kind":"other","planned":false,"acquired":false,"shares":8216,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"JATT distributed private placement warrants to its members with no consideration being paid in connection therewith."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"JATT distributed private placement warrants to its members with no consideration being paid in connection therewith."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":8216},"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267563,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-02-14T21:27:51.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":4133466,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"JATT distributed private placement warrants to its members with no consideration being paid in connection therewith."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"JATT distributed private placement warrants to its members with no consideration being paid in connection therewith."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":4133466},"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267562,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:27:51.000Z","date":"2024-09-04","kind":"other","planned":false,"acquired":false,"shares":593055,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"JATT transferred Class A ordinary shares to Willow Gate, LLC for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"JATT transferred Class A ordinary shares to Willow Gate, LLC for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":242055,"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267561,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:27:51.000Z","date":"2024-08-24","kind":"grant","planned":false,"acquired":true,"shares":721971,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."}],"balance_after":2807389,"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267560,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:27:51.000Z","date":"2024-08-24","kind":"grant","planned":false,"acquired":true,"shares":835110,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":242055,"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267559,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:27:51.000Z","date":"2023-11-21","kind":"other","planned":false,"acquired":false,"shares":351000,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"JATT transferred Class A ordinary shares to Willow Gate, LLC for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"JATT transferred Class A ordinary shares to Willow Gate, LLC for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":242055,"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267558,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:27:51.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":false,"shares":761370,"ownership":{"direct":false,"nature":"By JATT Ventures, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"JATT distributed Class A ordinary shares to its members with no consideration being paid in connection therewith."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"JATT distributed Class A ordinary shares to its members with no consideration being paid in connection therewith."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned by JATT. The Reporting Person is the sole director of the sole general partner of JATT and, as such, has voting and investment discretion with respect to the ordinary shares held by JATT. The Reporting Person may be deemed to have shared beneficial ownership of the ordinary shares held directly by JATT."}],"balance_after":242055,"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267557,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:27:51.000Z","date":"2023-09-22","kind":"other","planned":false,"acquired":false,"shares":200484,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were distributed by the Reporting Person to JATT Ventures, L.P. (\"JATT\") directors for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were distributed by the Reporting Person to JATT Ventures, L.P. (\"JATT\") directors for no additional consideration."}],"balance_after":2807389,"source":{"system":"sec-edgar","filing":"0001415889-25-004113","document":"form5-02142025_090247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004113/form5-02142025_090247.xml","form_type":"5"}},{"id":1267556,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2025-02-14T21:26:09.000Z","date":"2024-08-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":420519,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":420519},"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267555,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2025-02-14T21:26:09.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":true,"shares":420519,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The warrants were distributed by JATT to the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrants were distributed by JATT to the Reporting Person for no additional consideration."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":420519},"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267554,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:26:09.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":126155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."}],"balance_after":517519,"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267553,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:26:09.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":true,"shares":355880,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."}],"balance_after":517519,"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267552,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:26:09.000Z","date":"2023-09-22","kind":"other","planned":false,"acquired":true,"shares":35484,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."}],"balance_after":517519,"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1319892,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-12-31T21:15:04.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Member"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award, which vested in full immediately upon grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by the Reporting Person's family member. The Reporting Person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001415889-24-030312","document":"form4-12312024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924030312/form4-12312024_041201.xml","form_type":"4"}},{"id":1319891,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-12-31T21:15:04.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Member"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award, which vested in full immediately upon grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by the Reporting Person's family member. The Reporting Person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001415889-24-030312","document":"form4-12312024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924030312/form4-12312024_041201.xml","form_type":"4"}},{"id":1335865,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36383,"kind":"person","name":"Jarrett Jennifer","position":1,"cik":"0001671311","reported_name":"Jarrett Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:48:07.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028983","document":"form4-12112024_091204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028983/form4-12112024_091204.xml","form_type":"4"}},{"id":1335864,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79404,"kind":"person","name":"Graham Neil Murray Hamilton","position":1,"cik":"0001952700","reported_name":"Graham Neil Murray Hamilton","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:46:52.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028981","document":"form4-12112024_091249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028981/form4-12112024_091249.xml","form_type":"4"}},{"id":1335863,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:16.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028977","document":"form4-12112024_041213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028977/form4-12112024_041213.xml","form_type":"4"}},{"id":1335862,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:15.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028976","document":"form4-12112024_041211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028976/form4-12112024_041211.xml","form_type":"4"}},{"id":1335978,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":24198,"kind":"person","name":"Kulkarni Sandeep Chidambar","position":1,"cik":"0001945691","reported_name":"Kulkarni Sandeep Chidambar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:13.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028975","document":"form4-12112024_041209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945691/000141588924028975/form4-12112024_041209.xml","form_type":"4"}},{"id":1335861,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":34471,"kind":"person","name":"Munshi Amit","position":1,"cik":"0001612551","reported_name":"Munshi Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:12.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028974","document":"form4-12112024_041207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028974/form4-12112024_041207.xml","form_type":"4"}},{"id":1335860,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36382,"kind":"person","name":"Thiara Parvinder","position":1,"cik":"0001995535","reported_name":"Thiara Parvinder","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:10.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028973","document":"form4-12112024_041205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028973/form4-12112024_041205.xml","form_type":"4"}},{"id":1335859,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:07.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028972","document":"form4-12112024_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028972/form4-12112024_041203.xml","form_type":"4"}},{"id":1335858,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":82567,"kind":"person","name":"Lisicki Robert","position":1,"cik":"0001779614","reported_name":"Lisicki Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-12-11T21:45:04.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028971","document":"form4-12112024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028971/form4-12112024_041201.xml","form_type":"4"}},{"id":1349590,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36382,"kind":"person","name":"Thiara Parvinder","position":1,"cik":"0001995535","reported_name":"Thiara Parvinder","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2024-11-27T21:15:12.000Z","date":"2024-11-25","kind":"sale","planned":false,"acquired":false,"shares":1001633,"price":2.73,"value":2734458.09,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were disposed of by way of a private transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Athanor Master Fund, LP (the \"Master Fund\") and Athanor International Master Fund, LP (the \"International Master Fund\", and together with the Master Fund, the \"Funds\") are the direct holders of the securities reported herein. Athanor Capital Partners, LP (\"Master GP\") is the general partner of the Master Fund. Athanor Capital Partners GP, LLC (\"ACP GP\") is the general partner of Master GP. Athanor International Fund GP, LP (\"International Master GP\") is the general partner of the International Master Fund. Athanor International Fund Ultimate GP, LLC (\"AIFU GP\") is the general partner of International Master GP. Athanor Capital, LP (\"Athanor Capital\") is the investment adviser to the Funds. Athanor Capital GP, LLC (\"Athanor Capital GP\") is the general partner of Athanor Capital. Parvinder Thiara is the managing member of  Athanor Capital GP, AIFU GP and ACP GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By virtue of the foregoing relationships, Mr. Thiara and each of the entities named in footnote 2 above may be deemed to beneficially own the securities held by the Funds, however each of them disclaims beneficial ownership of such securities, except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-027847","document":"form4-11272024_041107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924027847/form4-11272024_041107.xml","form_type":"4"}},{"id":1407767,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36382,"kind":"person","name":"Thiara Parvinder","position":1,"cik":"0001995535","reported_name":"Thiara Parvinder","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2024-09-13T20:15:20.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":3800000,"price":2.7,"value":10260000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were disposed of by way of a private transaction dated September 11, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Athanor Master Fund, LP (the \"Master Fund\") and Athanor International Master Fund, LP (the \"International Master Fund\", and together with the Master Fund, the \"Funds\") are the direct holders of the securities reported herein. Athanor Capital Partners, LP (\"Master GP\") is the general partner of the Master Fund. Athanor Capital Partners GP, LLC (\"ACP GP\") is the general partner of Master GP. Athanor International Fund GP, LP (\"International Master GP\") is the general partner of the International Master Fund. Athanor International Fund Ultimate GP, LLC (\"AIFU GP\") is the general partner of International Master GP. Athanor Capital, LP (\"Athanor Capital\") is the investment adviser to the Funds. Athanor Capital GP, LLC (\"Athanor Capital GP\") is the general partner of Athanor Capital. Parvinder Thiara is the managing member of  Athanor Capital GP, AIFU GP and ACP GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By virtue of the foregoing relationships, Mr. Thiara and each of the entities named in footnote 2 above may be deemed to beneficially own the securities held by the Funds, however each of them disclaims beneficial ownership of such securities, except to the extent of his or its pecuniary interest therein."}],"balance_after":1001633,"source":{"system":"sec-edgar","filing":"0001415889-24-023366","document":"form4-09132024_040916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924023366/form4-09132024_040916.xml","form_type":"4"}},{"id":1411983,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54314,"kind":"person","name":"Nistala Kiran","position":1,"cik":"0002003539","reported_name":"Nistala Kiran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A ordinary shares","published_at":"2024-09-09T16:10:06.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":true,"shares":3195,"price":3.13,"value":10000.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share."}],"balance_after":3195,"source":{"system":"sec-edgar","filing":"0001415889-24-023064","document":"form4a-09092024_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003539/000141588924023064/form4a-09092024_040901.xml","form_type":"4/A","original_submission_date":"2024-04-24"}},{"id":1412822,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares","published_at":"2024-09-06T21:37:07.000Z","date":"2024-09-04","kind":"sale","planned":false,"acquired":false,"shares":51728,"price":3.87,"value":200187.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.86 to $3.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2085418,"source":{"system":"sec-edgar","filing":"0001415889-24-023032","document":"form4-09062024_090904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924023032/form4-09062024_090904.xml","form_type":"4"}},{"id":1412821,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares","published_at":"2024-09-06T21:34:02.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":true,"shares":1186901,"price":3.13,"value":3715000.13,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Pegasus LLC at a purchase price of $3.13 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares were acquired by Pegasus LLC. The Reporting Person is the sole member and beneficial owner of the limited liability company interests of Pegasus LLC."}],"balance_after":1186901,"source":{"system":"sec-edgar","filing":"0001415889-24-023030","document":"form4a-09062024_090959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924023030/form4a-09062024_090959.xml","form_type":"4/A","original_submission_date":"2024-04-24"}},{"id":1412820,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":34471,"kind":"person","name":"Munshi Amit","position":1,"cik":"0001612551","reported_name":"Munshi Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares","published_at":"2024-09-06T21:32:12.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":true,"shares":159744,"price":3.13,"value":499998.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share."}],"balance_after":777384,"source":{"system":"sec-edgar","filing":"0001415889-24-023028","document":"form4a-09062024_090909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924023028/form4a-09062024_090909.xml","form_type":"4/A","original_submission_date":"2024-04-24"}},{"id":1412819,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A ordinary shares","published_at":"2024-09-06T21:31:04.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":true,"shares":7987,"price":3.13,"value":24999.31,"ownership":{"direct":false,"nature":"By corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. (\"Mountaineer\") at a purchase price of $3.13 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":7987,"source":{"system":"sec-edgar","filing":"0001415889-24-023026","document":"form4a-09062024_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924023026/form4a-09062024_090901.xml","form_type":"4/A","original_submission_date":"2024-04-24"}},{"id":1437896,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A ordinary shares","published_at":"2024-08-08T20:15:07.000Z","date":"2024-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":9860,"price":6.05,"value":59653.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units."}],"balance_after":104535,"source":{"system":"sec-edgar","filing":"0001415889-24-020979","document":"form4-08082024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924020979/form4-08082024_040801.xml","form_type":"4"}},{"id":1472209,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:11:56.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":295000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001415889-24-017865","document":"form4-06212024_100652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017865/form4-06212024_100652.xml","form_type":"4"}},{"id":1472208,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54274,"kind":"person","name":"Whale Gary","position":1,"cik":"0001965860","reported_name":"Whale Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:10:44.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":280000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001415889-24-017864","document":"form4-06212024_100640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017864/form4-06212024_100640.xml","form_type":"4"}},{"id":1472207,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:10:17.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":420000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001415889-24-017863","document":"form4-06212024_060612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017863/form4-06212024_060612.xml","form_type":"4"}},{"id":1472206,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:10:14.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":420000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001415889-24-017862","document":"form4-06212024_060610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017862/form4-06212024_060610.xml","form_type":"4"}},{"id":1472205,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":82567,"kind":"person","name":"Lisicki Robert","position":1,"cik":"0001779614","reported_name":"Lisicki Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:10:12.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":1050000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001415889-24-017861","document":"form4-06212024_060608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017861/form4-06212024_060608.xml","form_type":"4"}},{"id":1472295,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54314,"kind":"person","name":"Nistala Kiran","position":1,"cik":"0002003539","reported_name":"Nistala Kiran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T18:10:08.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":285000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001415889-24-017860","document":"form4-06212024_060603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003539/000141588924017860/form4-06212024_060603.xml","form_type":"4"}},{"id":1503845,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares","published_at":"2024-05-23T12:53:36.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":80000,"price":6.2,"value":496000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $6.194848 to $6.199696 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-24-014179","document":"form4-05232024_120531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924014179/form4-05232024_120531.xml","form_type":"4"}},{"id":1536260,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A ordinary shares","published_at":"2024-04-24T22:54:25.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":7987,"price":3.13,"value":24999.31,"ownership":{"direct":false,"nature":"By corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. (\"Mountaineer\") at a purchase price of $3.13 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":7987,"source":{"system":"sec-edgar","filing":"0001415889-24-011482","document":"form4-04242024_100418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924011482/form4-04242024_100418.xml","form_type":"4"}},{"id":1536259,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":34471,"kind":"person","name":"Munshi Amit","position":1,"cik":"0001612551","reported_name":"Munshi Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares","published_at":"2024-04-24T22:52:14.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":159744,"price":3.13,"value":499998.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired in a private placement\ntransaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share."}],"balance_after":777384,"source":{"system":"sec-edgar","filing":"0001415889-24-011480","document":"form4-04242024_100408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924011480/form4-04242024_100408.xml","form_type":"4"}},{"id":1536258,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares","published_at":"2024-04-24T22:51:00.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":1186901,"price":3.13,"value":3715000.13,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Pegasus LLC at a purchase price of $3.13 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares were acquired by Pegasus LLC. The Reporting Person is the sole member and beneficial owner of the limited liability company interests of Pegasus LLC."}],"balance_after":1186901,"source":{"system":"sec-edgar","filing":"0001415889-24-011479","document":"form4-04242024_100449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924011479/form4-04242024_100449.xml","form_type":"4"}},{"id":1536296,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54314,"kind":"person","name":"Nistala Kiran","position":1,"cik":"0002003539","reported_name":"Nistala Kiran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A ordinary shares","published_at":"2024-04-24T18:53:25.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":3195,"price":3.13,"value":10000.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share."}],"balance_after":3195,"source":{"system":"sec-edgar","filing":"0001415889-24-011481","document":"form4-04242024_100419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003539/000141588924011481/form4-04242024_100419.xml","form_type":"4"}},{"id":1669755,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":82567,"kind":"person","name":"Lisicki Robert","position":1,"cik":"0001779614","reported_name":"Lisicki Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock options","published_at":"2024-01-26T16:33:20.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase 1,000,000 Class A Ordinary Shares. The vesting for 600,000 of 1,000,000 shares began on January 8, 2024 and would vest over a period of four years, with 1/4 to be vested on 01/08/2025, and thereafter 1/48 on a monthly basis. The vesting for 400,000 of 1,000,000 shares shall begin on the date of Mr. Lisicki's promotion and shall vest over a period of four years, with 1/4 to be vested on the first anniversary of the promotion date, and thereafter 1/48 on a monthly basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of options to purchase 1,000,000 Class A Ordinary Shares. The vesting for 600,000 of 1,000,000 shares began on January 8, 2024 and would vest over a period of four years, with 1/4 to be vested on 01/08/2025, and thereafter 1/48 on a monthly basis. The vesting for 400,000 of 1,000,000 shares shall begin on the date of Mr. Lisicki's promotion and shall vest over a period of four years, with 1/4 to be vested on the first anniversary of the promotion date, and thereafter 1/48 on a monthly basis."}],"balance_after":1000000,"derivative":{"exercise_price":3.98,"expiration_date":"2034-01-24","underlying":"Class A Ordinary Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001104659-24-007066","document":"tm244212-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924007066/tm244212-4_4seq1.xml","form_type":"4"}},{"id":1669754,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2024-01-26T16:32:02.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":48149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase 48,149 Class A Ordinary Shares. The vesting for 48,149 shares began on November 9, 2023 and would vest over a period of three years, with each 1/3 on an annual basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of options to purchase 48,149 Class A Ordinary Shares. The vesting for 48,149 shares began on November 9, 2023 and would vest over a period of three years, with each 1/3 on an annual basis."}],"balance_after":48149,"derivative":{"exercise_price":3.98,"expiration_date":"2034-01-24","underlying":"Class A Ordinary Shares","underlying_shares":48149},"source":{"system":"sec-edgar","filing":"0001104659-24-007065","document":"tm244212-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924007065/tm244212-3_4seq1.xml","form_type":"4"}},{"id":1669753,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36382,"kind":"person","name":"Thiara Parvinder","position":1,"cik":"0001995535","reported_name":"Thiara Parvinder","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock options","published_at":"2024-01-26T16:30:45.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":48149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase 48,149 Class A Ordinary Shares. The vesting for 48,149 shares began on June 22, 2023 and would vest over a period of three years, with each 1/3 on an annual basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of options to purchase 48,149 Class A Ordinary Shares. The vesting for 48,149 shares began on June 22, 2023 and would vest over a period of three years, with each 1/3 on an annual basis."}],"balance_after":48149,"derivative":{"exercise_price":3.98,"expiration_date":"2034-01-24","underlying":"Class A Ordinary Shares","underlying_shares":48149},"source":{"system":"sec-edgar","filing":"0001104659-24-007064","document":"tm244212-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924007064/tm244212-2_4seq1.xml","form_type":"4"}},{"id":1669835,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54314,"kind":"person","name":"Nistala Kiran","position":1,"cik":"0002003539","reported_name":"Nistala Kiran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock options","published_at":"2024-01-26T11:27:15.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase 350,000 Class A Ordinary Shares. The vesting for 350,000 shares began on November 27, 2023 and would vest over a period of four years, with 1/4 to be vested on 11/27/2024, and thereafter 1/48 on a monthly basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of options to purchase 350,000 Class A Ordinary Shares. The vesting for 350,000 shares began on November 27, 2023 and would vest over a period of four years, with 1/4 to be vested on 11/27/2024, and thereafter 1/48 on a monthly basis."}],"balance_after":350000,"derivative":{"exercise_price":3.98,"expiration_date":"2034-01-24","underlying":"Class A Ordinary Shares","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001104659-24-007062","document":"tm244212-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003539/000110465924007062/tm244212-1_4seq1.xml","form_type":"4"}},{"id":1711119,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36382,"kind":"person","name":"Thiara Parvinder","position":1,"cik":"0001995535","reported_name":"Thiara Parvinder","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2023-12-14T20:35:26.000Z","date":"2023-12-12","kind":"sale","planned":false,"acquired":false,"shares":2000000,"price":4,"value":8000000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Athanor Master Fund, LP (the \"Master Fund\") and Athanor International Master Fund, LP (the \"International Master Fund\", and together with the Master Fund, the \"Funds\") are the direct holders of the securities reported herein. Athanor Capital Partners, LP (\"Master GP\") is the general partner of the Master Fund. Athanor Capital Partners GP, LLC is the general partner of Master GP. Athanor International Fund GP, LP (\"International Master GP\") is the general partner of the International Master Fund. Athanor International Fund Ultimate GP, LLC is the general partner of International Master GP. Athanor Capital, LP (\"Athanor Capital\") is the investment adviser to the Funds. Athanor Capital GP, LLC is the general partner of Athanor Capital. Parvinder Thiara is the managing member of Athanor Capital Partners GP, LLC, Athanor International Fund Ultimate GP, LLC and Athanor Capital GP, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By virtue of the foregoing relationships, Mr. Thiara and each of the entities named in this footnote may be deemed to beneficially own the securities held by the Funds, however each of them disclaims beneficial ownership of such securities, except to the extent of his or its pecuniary interest therein."}],"balance_after":4801633,"source":{"system":"sec-edgar","filing":"0001104659-23-126005","document":"tm2332936-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923126005/tm2332936-1_4seq1.xml","form_type":"4"}},{"id":1712743,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2023-12-13T20:13:06.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":1750000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the warrants at $0.33 per warrant pursuant to certain purchase agreement dated December 11, 2023."}],"balance_after":1750000,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":1750000},"source":{"system":"sec-edgar","filing":"0001104659-23-125675","document":"tm2332812-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923125675/tm2332812-1_4seq1.xml","form_type":"4"}},{"id":1846662,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":105211,"kind":"organization","name":"Athanor Capital, LP","position":1,"cik":"0001730574","reported_name":"Athanor Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-06-22T21:21:08.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":1194000,"price":0.25,"value":298500.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Athanor Master Fund, LP (the \"Master Fund\") and Athanor International Master Fund, LP (the \"International Master Fund\", and together with the Master Fund, the \"Funds\") are the direct holders of the securities reported herein. Athanor Capital Partners, LP (\"Master GP\") is the general partner of the Master Fund. Athanor Capital Partners GP, LLC is the general partner of Master GP. Athanor International Fund GP, LP (\"International Master GP\") is the general partner of the International Master Fund. Athanor International Fund Ultimate GP, LLC is the general partner of International Master GP. Athanor Capital, LP (\"Athanor Capital\") is the investment adviser to the Funds. Athanor Capital GP, LLC is the general partner of Athanor Capital. Parvinder Thiara is the managing member of Athanor Capital Partners GP, LLC, Athanor International Fund Ultimate GP, LLC and Athanor Capital GP, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"(Continued from footnote 1) By virtue of the foregoing relationships, Mr. Thiara and each of the entities named in this footnote may be deemed to beneficially own the securities held by the Funds, however each of them disclaims beneficial ownership of such securities, except to the extent of his or its pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-03-20","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":1194000},"source":{"system":"sec-edgar","filing":"0000904454-23-000408","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000090445423000408/ownership.xml","form_type":"4"}},{"id":1867376,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":34471,"kind":"person","name":"Munshi Amit","position":1,"cik":"0001612551","reported_name":"Munshi Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2023-06-05T23:15:15.000Z","date":"2023-06-05","kind":"purchase","planned":false,"acquired":true,"shares":117647,"price":4.25,"value":499999.75,"ownership":{"direct":true},"balance_after":617640,"source":{"system":"sec-edgar","filing":"0001104659-23-068206","document":"tm2310288-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923068206/tm2310288-1_4seq1.xml","form_type":"4"}},{"id":1870244,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":34471,"kind":"person","name":"Munshi Amit","position":1,"cik":"0001612551","reported_name":"Munshi Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-06-03T00:45:24.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":1130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted an option to purchase 1,130,000 Class A Ordinary Shares of the Issuer (the \"Option\") on June 1, 2023 (the \"Grant Date\"). The Option is vested and nonforfeitable as of the Grant Date. 25% of the Option shall become exercisable on June 1, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter."}],"balance_after":1130000,"derivative":{"exercise_price":6.25,"expiration_date":"2033-06-01","underlying":"Class A Ordinary Shares","underlying_shares":1130000},"source":{"system":"sec-edgar","filing":"0001104659-23-067722","document":"tm2317618-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923067722/tm2317618-1_4seq1.xml","form_type":"4"}},{"id":1882818,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54274,"kind":"person","name":"Whale Gary","position":1,"cik":"0001965860","reported_name":"Whale Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:19:53.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":95329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Employee Share Option is a nil cost option granted under the Issuer's 2023 Equity Incentive Plan and the applicable UK Subplan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shall become exercisable on May 18, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter."}],"balance_after":95329,"derivative":{"exercise_price":0.01,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":95329},"source":{"system":"sec-edgar","filing":"0001104659-23-063323","document":"tm2316481-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063323/tm2316481-12_4seq1.xml","form_type":"4"}},{"id":1882817,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":18962,"kind":"person","name":"Sidhu Someit","position":1,"cik":"0001870329","reported_name":"Sidhu Someit","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:19:07.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":1950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Employee Share Option is a nil cost option granted under the Issuer's 2023 Equity Incentive Plan and the applicable UK Subplan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shall become exercisable on May 18, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter."}],"balance_after":1950000,"derivative":{"exercise_price":0.01,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":1950000},"source":{"system":"sec-edgar","filing":"0001104659-23-063322","document":"tm2316481-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063322/tm2316481-11_4seq1.xml","form_type":"4"}},{"id":1882816,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:18:35.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":7652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become fully exercisable on the earlier of (i) May 18, 2024 or (ii) the date of the next annual meeting of shareholders of Zura Bio Limited."}],"balance_after":7652,"derivative":{"exercise_price":5.31,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":7652},"source":{"system":"sec-edgar","filing":"0001104659-23-063320","document":"tm2316481-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063320/tm2316481-10_4seq1.xml","form_type":"4"}},{"id":1882814,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":35024,"kind":"person","name":"NEIL GARRY ARTHUR","position":1,"cik":"0001586785","reported_name":"NEIL GARRY ARTHUR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:18:02.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":7652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become fully exercisable on the earlier of (i) May 18, 2024 or (ii) the date of the next annual meeting of shareholders of Zura Bio Limited."}],"balance_after":7652,"derivative":{"exercise_price":5.31,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":7652},"source":{"system":"sec-edgar","filing":"0001104659-23-063319","document":"tm2316481-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063319/tm2316481-9_4seq1.xml","form_type":"4"}},{"id":1882902,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":24198,"kind":"person","name":"Kulkarni Sandeep Chidambar","position":1,"cik":"0001945691","reported_name":"Kulkarni Sandeep Chidambar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:17:39.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":207520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shall become exercisable on May 18, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter."}],"balance_after":207520,"derivative":{"exercise_price":5.31,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":207520},"source":{"system":"sec-edgar","filing":"0001104659-23-063318","document":"tm2316481-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945691/000110465923063318/tm2316481-7_4seq1.xml","form_type":"4"}},{"id":1882815,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36383,"kind":"person","name":"Jarrett Jennifer","position":1,"cik":"0001671311","reported_name":"Jarrett Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:17:23.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":7652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become fully exercisable on the earlier of (i) May 18, 2024 or (ii) the date of the next annual meeting of shareholders of Zura Bio Limited."}],"balance_after":7652,"derivative":{"exercise_price":5.31,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":7652},"source":{"system":"sec-edgar","filing":"0001104659-23-063317","document":"tm2316481-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063317/tm2316481-6_4seq1.xml","form_type":"4"}},{"id":1882812,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":87747,"kind":"person","name":"Howell Michael","position":1,"cik":"0001970231","reported_name":"Howell Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Ordinary Shares","published_at":"2023-05-23T01:17:10.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":114395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted an award of 114,395 Restricted Share Units (\"RSUs\") on May 18, 2023 (the \"Grant Date\"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":114395,"source":{"system":"sec-edgar","filing":"0001104659-23-063316","document":"tm2316481-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063316/tm2316481-5_4seq1.xml","form_type":"4"}},{"id":1882813,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79404,"kind":"person","name":"Graham Neil Murray Hamilton","position":1,"cik":"0001952700","reported_name":"Graham Neil Murray Hamilton","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:16:46.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":7652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become fully exercisable on the earlier of (i) May 18, 2024 or (ii) the date of the next annual meeting of shareholders of Zura Bio Limited."}],"balance_after":7652,"derivative":{"exercise_price":5.31,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":7652},"source":{"system":"sec-edgar","filing":"0001104659-23-063315","document":"tm2316481-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063315/tm2316481-4_4seq1.xml","form_type":"4"}},{"id":1882811,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":54273,"kind":"person","name":"Davis Kim","position":1,"cik":"0001965590","reported_name":"Davis Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2023-05-23T01:16:25.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":492381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted an award of 492,381 Restricted Share Units (\"RSUs\") on May 18, 2023 (the \"Grant Date\"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":492381,"source":{"system":"sec-edgar","filing":"0001104659-23-063313","document":"tm2316481-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063313/tm2316481-3_4seq1.xml","form_type":"4"}},{"id":1882810,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":64958,"kind":"person","name":"Cabell Christopher","position":1,"cik":"0001814928","reported_name":"Cabell Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & Head of R&D"}}],"security":"Class A Ordinary Shares","published_at":"2023-05-23T01:15:56.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":162060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted an award of 162,060 Restricted Share Units (\"RSUs\") on May 18, 2023 (the \"Grant Date\"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":162060,"source":{"system":"sec-edgar","filing":"0001104659-23-063312","document":"tm2316481-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063312/tm2316481-2_4seq1.xml","form_type":"4"}},{"id":1882809,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:15:41.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Employee Share Option is a nil cost option granted under the Issuer's 2023 Equity Incentive Plan and the applicable UK Subplan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shall become exercisable on May 18, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter."}],"balance_after":575000,"derivative":{"exercise_price":0.01,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001104659-23-063311","document":"tm2316481-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063311/tm2316481-1_4seq1.xml","form_type":"4"}},{"id":1940320,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":25809,"kind":"organization","name":"Owl Creek Asset Management, L.P.","position":1,"cik":"0001313756","reported_name":"Owl Creek Asset Management, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25808,"kind":"person","name":"ALTMAN JEFFREY A","position":2,"cik":"0001269751","reported_name":"ALTMAN JEFFREY A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares, par value $0.0001 per share","published_at":"2023-03-23T14:57:21.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":550000,"price":10.4048,"value":5722640.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of the Issuer's business combination, the shares held by OCCOMF (as defined below) were redeemed."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities to which this filing relates were held directly by Owl Creek Credit Opportunities Master Fund, L.P., a Cayman Islands exempted limited partnership (\"OCCOMF\"), to which Owl Creek Asset Management, L.P., a Delaware limited partnership, (the \"Investment Manager\") serves as investment manager. Jeffrey A. Altman (\"Mr. Altman\") is the managing member of the general partner of the Investment Manager. Each of the Investment Manager and Mr. Altman disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000902664-23-002357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000090266423002357/ownership.xml","form_type":"4"}}],"next_cursor":"2023-03-23T14:57:21.000000Z,1940320"}